Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to ONO-4538 in Patients With Rhabdoid Tumor
Sponsor: Ono Pharmaceutical Co., Ltd.
Summary
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
Official title: A Multicenter, Open-label, Uncontrolled Phase II Study to Investigate Efficacy and Safety of ONO4538 in Patients With Rhabdoid Tumor
Key Details
Gender
All
Age Range
1 Year - Any
Study Type
INTERVENTIONAL
Enrollment
23
Start Date
2024-11-25
Completion Date
2030-03-31
Last Updated
2026-08-04
Healthy Volunteers
No
Conditions
Interventions
ONO-4538
every 2 weeks
Locations (14)
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Hyogo Prefectural Kobe Children's Hospital
Kobe, Hyōgo, Japan
Osaka City General Hospital
Osaka, Osaka, Japan
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
Chiba University Hospital
Chiba, Japan
Kyushu University Hospital
Fukuoka, Japan
Fukushima Medical University Hospital
Fukushima, Japan
Hiroshima University Hospital
Hiroshima, Japan
Kanazawa University Hospital
Kanazawa, Japan
University Hospital, Kyoto Prefectural University of Medicine
Kyoto, Japan
Tohoku University Hospital
Miyagi, Japan
Niigata University Medical & Dental Hospital
Niigata, Japan
National Center for Child Health and Development
Tokyo, Japan